18
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Bilateral Sequential Vision Loss in a Patient Re-Challenged with Amiodarone

, , , , &
Pages 260-265 | Received 02 Jun 2008, Published online: 08 Jul 2009

REFERENCES

  • Mantyjarvi M, Tuppurainen K, Ikaheimo K. Ocular side effects of amiodarone. Surv Ophthalmol. 1998; 42: 360–366
  • Gittinger JW, Jr, Asdourian GK. Papillopathy caused by amiodarone. Arch Ophthalmol. 1987; 105: 349–351
  • Feiner LA, Younge BR, Kazmier FJ, Stricker BH, Fraunfelder FT. Optic neuropathy and amiodarone therapy. Mayo Clin Proc. 1987; 62: 702–717
  • Speicher MA, Goldman MH, Chrousos GA. Amiodarone optic neuropathy without disc edema. J Neuroophthalmol. 2000; 20: 171–172
  • Sedwick LA. Getting to the heart of visual loss: When cardiac medication may be dangerous to the optic nerves. Surv Ophthalmol. 1992; 36: 366–372
  • Castells DD, Teitelbaum BA, Tresley DJ. Visual changes secondary to initiation of amiodarone: A case report and review involving ocular management in cardiac polypharmacy. Optometry. 2002; 73: 113–121
  • Nagra PK, Foroozan R, Savino PJ, Castillo I, Sergott RC. Amiodarone induced optic neuropathy. Br J Ophthalmol. 2003; 87: 420–422
  • Younge BR. Amiodarone and ischemic optic neuropathy. J NeuroOhthalmol. 2007; 27: 85–86
  • AAO Syllabus. Drug-related adverse effects of clinical importance to the ophthalmologist. 2002. 2002, Available at: http://piodr.sterling.net/staticContent/AAO%20Syllabus%202002.pdf Accessed October 15, 2007
  • Santaella RM, Fraunfelder FW. Ocular adverse effects associated with systemic medications : Recognition and management. Drugs. 2007; 67: 75–93
  • Mindel JS. Amiodarone and optic neuropathy: A medicolegal issue. Surv Ophthalmol. 1998; 42: 358–359
  • Mathews MK. Nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol. 2005; 16: 341–345
  • Lee KE, Klein BE, Klein R, Meuer SM. Association of retinal vessel caliber to optic disc and cup diameters. Invest Ophthalmol Vis Sci. 2007; 48: 63–67
  • Desai N, Patel MR, Prisant LM, Thomas DA. Nonarteritic anterior ischemic optic neuropathy. J Clin Hypertens (Greenwich). 2005; 7: 130–133
  • Johnson LN, Krohel GB, Thomas ER. The clinical spectrum of amiodaroneassociated optic neuropathy. J Natl Med Assoc. 2004; 96: 1477–1491
  • Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997; 123: 103–107
  • Purvin V, Kawasaki A, Borruat FX. Optic neuropathy in patients using amiodarone. Arch Ophthalmol. 2006; 124: 696–701
  • Macaluso DC, Shults WT, Fraunfelder FT. Features of amiodarone-induced optic neuropathy. Am J Ophthalmol. 1999; 127: 610–612
  • Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000; 356: 1255–1259
  • Murphy MA, Murphy JF. Amiodarone and optic neuropathy:The heart of the matter. J Neuroophthalmol. 2005; 25: 232–236
  • Mindel JS, Anderson J, Hellkamp A, et al. Absence of bilateral vision loss from amiodarone: A randomized trial. Am Heart J. 2007; 153: 837–842
  • Mansour AM, Puklin JE, O’Grady R. Optic nerve ultrastructure following amiodarone therapy. J Clin Neuroophthalmol. 1988; 8: 231–237
  • Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000; 26: 207–210
  • Anikster Y, Kleta R, Shaag A, Gahl WA, Elpeleg O. Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): Identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet. 2001; 69: 1218–1224
  • Newman NJ. From genotype to phenotype in Leber hereditary optic neuropathy: Still more questions than answers. J Neuroophthalmol. 2002; 22: 257–261
  • Züchner S, De Jonghe P, Jordanova A, et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol. 2006; 59: 276–281
  • Fromenty B, Fisch C, Berson A, Letteron P, Larrey D, Pessayre D. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther. 1990; 255: 1377–1384
  • Nicolescu AC, Ji Y, Comeau JL, Hill BC, Takahashi T, Brien JF, Racz WJ, Massey TE. Direct mitochondrial dysfunction precedes reactive oxygen species production in amiodarone-induced toxicity in human peripheral lung epithelial HPL1A cells. Toxicol Appl Pharmacol. 2007; 227(3)370–379
  • Vassallo P, Trohman RG. Prescribing amiodarone: An evidence-based review of clinical indications. JAMA. 2007; 298: 1312–1322

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.